Vaccination Targeting a Surface Sialidase of P. acnes: Implication for New Treatment of Acne Vulgaris
2008

Vaccine Targeting Sialidase for Acne Treatment

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Nakatsuji Teruaki, Liu Yu-Tsueng, Huang Cheng-Po, Gallo Richard L., Huang Chun-Ming

Primary Institution: University of California San Diego

Hypothesis

Can a vaccine targeting the sialidase of Propionibacterium acnes provide a new treatment for acne vulgaris?

Conclusion

The study suggests that a vaccine targeting sialidase may effectively reduce inflammation and cytotoxicity associated with acne vulgaris.

Supporting Evidence

  • Mice immunized with sialidase showed reduced ear swelling after P. acnes challenge.
  • Sialidase treatment increased the susceptibility of sebocytes to P. acnes.
  • Anti-sialidase serum neutralized the cytotoxicity of P. acnes in vitro.

Takeaway

Researchers created a vaccine to help fight acne by targeting a specific part of the bacteria that causes it, which could help people with acne feel better.

Methodology

Mice were vaccinated with recombinant sialidase and then challenged with live P. acnes to assess immune response and inflammation.

Participant Demographics

ICR mice, approximately 3 months old.

Statistical Information

P-Value

p<0.0005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0001551

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication